🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label pharmacokinetic RBT dose-finding study in young (≤ 5 year old) H...
Status
Unknown
Location
Harriet Shezi Children's Clinic, Chris Hani Baragwanath Hospital, WHI, University of the Witwatersrand
Start Date
2010-11
Trial ID
NCT01259219
Treatments Being Tested
The "test and treat" strategy for treating dyspeptic patients who are H. py...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2013-11
Trial ID
NCT01980095
This is a Phase I, single-center, open-label, fixed-sequence, 2-period cros...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-06
Trial ID
NCT03149848
Treatments Being Tested
Multi-center, prospective study is performed to investigate the efficacy of...
Status
Unknown
Location
Shanghai Pulmonary Hospital
Start Date
2013-06
Trial ID
NCT02331823
Treatments Being Tested
To compared the efficacy and safety of rifampicin and rifabutin which inclu...
Status
Unknown
Location
Shanghai Public Health Clinical Center
Start Date
2018-04-15
Trial ID
NCT03478033
Treatments Being Tested
The investigators hypothesize that Mycobacterium avium paratuberculosis pos...
Status
Completed
Location
RedHill MS Clinical Trial Site 002
Start Date
2013-06
Trial ID
NCT01717664
Treatments Being Tested
To evaluate the pharmacokinetics (PK) of SPR719, the active moiety, generat...
Status
Terminated
Location
Medical Facility
Start Date
2020-12-03
Trial ID
NCT04553406
Treatments Being Tested
The study assesses PK and safety of other drugs, such as some antibiotics, ...
Status
Completed
Location
Central Clinical City Hospital
Start Date
2018-11-14
Trial ID
NCT03709355
Treatments Being Tested
The purpose of this study is to provide dosing recommendations for the coad...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-05-14
Trial ID
NCT02138084
Treatments Being Tested
The purpose of this study is to evaluate the safety, pharmacokinetics, and ...
Status
Completed
Location
Emory University DAIDS TB Non-Network CRS
Start Date
2020-10-27
Trial ID
NCT03891901